RE: RE: CHEMOPREVENTION OF UROLOGICAL CANCER
- 1 October 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (4) , 1321-1322
- https://doi.org/10.1016/s0022-5347(05)67184-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levelBritish Journal of Cancer, 1999
- Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissueThe Journal of Steroid Biochemistry and Molecular Biology, 1999
- Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trialUrology, 1998
- The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levelsBritish Journal of Cancer, 1998
- LOCALIZATION BY IN SITU HYBRIDIZATION OF STEROID 5 alpha-REDUCTASE ISOZYME GENE EXPRESSION IN THE HUMAN PROSTATE AND PREPUTIAL SKINJournal of Urology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- TWO CONSECUTIVE SETS OF TRANSRECTAL ULTRASOUND GUIDED SEXTANT BIOPSIES OF THE PROSTATE FOR THE DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- Differential Gene Expression of Steroid 5 -Reductase 2 in Core Needle Biopsies from Malignant and Benign Prostatic TissueJournal of Clinical Endocrinology & Metabolism, 1997
- 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitroJournal of Clinical Endocrinology & Metabolism, 1996
- Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasiaUrology, 1994